Improving antivenom availability and accessibility: Science, technology, and beyond
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The storage, accessibility, and administration of antivenom also pose significant practical challenges in rural areas where it is needed most (10, 37, 42, 43, 44, 45, 46, 47, 48).”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 67
- Abubakar, 2010, Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scale or carpet vipers (Echis ocellatus) in northern Nigeria, Toxicon, 55, 719, 10.1016/j.toxicon.2009.10.024 · doi:10.1016/j.toxicon.2009.10.024
- Abubakar, 2010, Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scale or carpet viper (Echis ocellatus) envenoming in Nigeria, PLoS Negl. Trop. Dis., 4, e767, 10.1371/journal.pntd.0000767 · DOI
- Abubakar, 2010, Amputation and disability following snakebite in Nigeria, Trop. Doct., 40, 114, 10.1258/td.2009.090266 · doi:10.1258/td.2009.090266
- Alape-Girón, 2008, Snake venomics of the lancehead pitviper Bothrops asper: geographic, individual, and ontogenetic variations, J. Proteome Res., 7, 3556, 10.1021/pr800332p · DOI · Paper page
- Alirol, 2010, Snake bite in South Asia: a review, PLoS Negl. Trop. Dis., 4, e603, 10.1371/journal.pntd.0000603 · DOI · Paper page
- Arroyo, 1999, Envenenamiento por mordedura de serpiente en Costa Rica en 1996: epidemiología y consideraciones clínicas, Acta Médica Costarricense, 41, 23, 10.51481/amc.v41i4.528 · doi:10.51481/amc.v41i4.528
- Burnouf, 2004, Assessment of the viral safety of antivenoms fractionated from equine plasma, Biologicals, 32, 115, 10.1016/j.biologicals.2004.07.001 · DOI
- Calvete, 2011, Proteomic tools against the neglected pathology of snake bite envenoming, Expert Rev. Proteomics, 8, 739, 10.1586/epr.11.61 · DOI · Paper page
- Calvete, 2010, Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa, Am. J. Trop. Med. Hyg., 82, 1194, 10.4269/ajtmh.2010.09-0733 · DOI
- Cardoso, 1993, Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in São Paulo, Brazil. Q. J. Med., 86, 315
- Chippaux, 1998, Snake-bites: appraisal of the global situation, Bull. World Health Organ., 76, 515
- Chippaux, 2011, Estimate of the burden of snakebites in sub-Saharan Africa: a meta-analytic approach, Toxicon, 57, 588, 10.1016/j.toxicon.2010.12.022 · DOI
- Chippaux, 1998, Clinical safety of a polyvalent F(ab′)2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon, Trans. R. Soc. Trop. Med. Hyg., 92, 657, 10.1016/S0035-9203(98)90802-1 · doi:10.1016/s0035-9203(98)90802-1
- Chippaux, 2007, Clinical trial of an F(ab′)2 polyvalent equine antivenom for African snake bites in Benin, Am. J. Trop. Med. Hyg., 77, 538, 10.4269/ajtmh.2007.77.538 · DOI
- Chippaux, 1991, Snake venom variability: methods of study, results and interpretation, Toxicon, 29, 1279, 10.1016/0041-0101(91)90116-9 · DOI · Paper page
- Guidolin, 2010, Polyvalent horse F(ab′)2 snake antivenom: development of process to produce polyvalent horse F(ab′)2 antibodies anti-African snake venom, African J. Biotechnol., 9, 2446
- Gutiérrez, 2011, Envenenamientos por mordeduras de serpientes en América Latina y el Caribe: Una visión integral de carácter regional, Bol. Malariol. Salud Ambiental, 51, 1
- Gutiérrez, J.M., in press. Snakebite envenoming: a public health perspective. In: Maddock, J. (Ed.), Public Health: Epidemiology, Environmental and System Issues. Intech, Croatia.
- Gutiérrez, 2009, Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop, Toxicon, 53, 625, 10.1016/j.toxicon.2009.01.020 · doi:10.1016/j.toxicon.2009.01.020
- Gutiérrez, 2007, Strengthening antivenom production in Central and South American public laboratories: report of a workshop, Toxicon, 49, 30, 10.1016/j.toxicon.2006.09.005 · doi:10.1016/j.toxicon.2006.09.005
- Gutiérrez, 2011, Antivenoms for the treatment of snakebite envenomings: the road ahead, Biologicals, 39, 129, 10.1016/j.biologicals.2011.02.005 · DOI · Paper page
- Gutiérrez, 2009, Snake venomics and antivenomics: proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming, J. Proteomics, 72, 165, 10.1016/j.jprot.2009.01.008 · DOI · Paper page
- Gutiérrez, 2005, Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa, Trans. R. Soc. Trop. Med. Hyg., 99, 468, 10.1016/j.trstmh.2004.09.014 · doi:10.1016/j.trstmh.2004.09.014
- Gutiérrez, 2006, Confronting the neglected problem of snake bite envenoming: the need for a global partnership, PLoS Med., 3, e150, 10.1371/journal.pmed.0030150 · DOI · Paper page
- Gutiérrez, 2010, Snakebite envenoming from a global perspective: towards an integrated approach, Toxicon, 56, 1223, 10.1016/j.toxicon.2009.11.020 · DOI · Paper page
- Habib, 2001, Snake bite in Nigeria, African J. Med. Med. Sci., 30, 171
- Hansson, 2010, Mapping snakebite epidemiology in Nicaragua. Pitfalls and possible solutions, PLoS Negl. Trop. Dis., 4, e896, 10.1371/journal.pntd.0000896 · doi:10.1371/journal.pntd.0000896
- Harrison, 2009, Snakebite envenoming: a disease of poverty, PLoS Negl. Trop. Dis., 3, e569, 10.1371/journal.pntd.0000569 · DOI · Paper page
- Hasan, 2012, The impact of snake bite on household economy in Bangladesh, Trop. Doct., 42, 41, 10.1258/td.2011.110137 · doi:10.1258/td.2011.110137
- Ho, 2011, Economical value of vaccines for the developing countries-The case of Instituto Butantan, a public institution in Brazil, PLoS Negl. Trop. Dis., 5, e1300, 10.1371/journal.pntd.0001300 · doi:10.1371/journal.pntd.0001300
- Hotez, 2007, Control of neglected tropical diseases, N. Engl. J. Med., 357, 1018, 10.1056/NEJMra064142 · DOI · Paper page
- Jiménez-Porras, 1964, Intraspecific variations in composition of venom of the jumping viper, Bothrops numifera, Toxicon, 2, 187, 10.1016/0041-0101(64)90021-2 · doi:10.1016/0041-0101(64)90021-2
- Kasturiratne, 2008, The global burden of snakebite: a literature analysis and modelling base don regional estimates of envenoming and deaths, PLoS Med., 5, e218, 10.1371/journal.pmed.0050218 · DOI · Paper page
- Lalloo, 1995, Snake bites by the Papuan taipan (Oxyuranus scutellatus canni): paralysis, hemostatic and electrocardiographic abnormalities, and effects of antivenom, Am. J. Trop. Med. Hyg., 52, 525, 10.4269/ajtmh.1995.52.525 · doi:10.4269/ajtmh.1995.52.525
- Leynaud, 2009, Identificación de las zonas de riesgo ofídico en Córdoba, Argentina, mediante el programa SIGEpi, Rev. Panam. Salud Pública, 26, 64, 10.1590/S1020-49892009000700010 · doi:10.1590/s1020-49892009000700010
- Lomonte, 2008, Snake venomics and antivenomics of the arboreal neotropical pitvipers Bothriechis lateralis and Bothriechis schlegelii, J. Proteome Res., 7, 2445, 10.1021/pr8000139 · DOI
- Méndez, 2011, Comparative study of the cytolytic activity of snake venoms from African spitting cobras (Naja spp, Elapidae) and its neutralization by a polyspecific antivenom, Toxicon, 58, 558, 10.1016/j.toxicon.2011.08.018 · DOI
- Michael, 2010, The effect of pre-hospital care for venomous snake bite on outcome in Nigeria, Trans. R. Soc. Trop. Med. Hyg., 105, 95, 10.1016/j.trstmh.2010.09.005 · doi:10.1016/j.trstmh.2010.09.005
- Mohapatra, 2011, Snakebite mortality in India: a nationally representative mortality survey, PLoS Negl. Trop. Dis., 5, e1018, 10.1371/journal.pntd.0001018 · DOI · Paper page
- Morel, 2005, Health innovation networks to help developing countries address neglected diseases, Science, 309, 401, 10.1126/science.1115538 · DOI · Paper page
- Moreno, 2011, The struggle of neglected scientific groups: ten years of NeTropica efforts to promote research in tropical diseases in Central America, PLoS Negl. Trop. Dis., 5, e1055, 10.1371/journal.pntd.0001055 · doi:10.1371/journal.pntd.0001055
- Otero, 2000, Snakebites and ethnobotany in the northwestern region of Colombia: Part I: Traditional use of plants, J. Ethnopharmacol., 71, 493, 10.1016/S0378-8741(00)00243-9 · DOI
- Petras, 2011, Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the pan-African EchiTAb-Plus-ICP antivenom by antivenomics and neutralization approaches, J. Proteome Res., 10, 1266, 10.1021/pr101040f · DOI · Paper page
- Prasad, 1999, Comparative characterization of Russell's viper (Daboia/Vipera russelli) venoms from different regions of the Indian peninsula, Biochim. Biophys. Acta, 1428, 121, 10.1016/S0304-4165(99)00053-7 · DOI
- Pugh, 1980, Incidence and mortality on snake bite in savanna Nigeria, Lancet, 2, 1181, 10.1016/S0140-6736(80)92608-2 · doi:10.1016/s0140-6736(80)92608-2
- Rahman, 2010, Annual incidence of snake bite in rural Bangladesh, PLoS Negl. Trop. Dis., 4, e860, 10.1371/journal.pntd.0000860 · doi:10.1371/journal.pntd.0000860
- Ramos-Cerrillo, 2008, Characterization of a new polyvalent antivenom (Antivipmyn Africa) against African vipers and elapids, Toxicon, 52, 881, 10.1016/j.toxicon.2008.09.002 · doi:10.1016/j.toxicon.2008.09.002
- Rodrigues-Silva, 1999, Thermal stability studies of hyperimmune horse antivenoms, Toxicon, 37, 33, 10.1016/S0041-0101(97)00101-3 · doi:10.1016/s0041-0101(97)00101-3
- Segura, 2010, Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms, Toxicon, 56, 980, 10.1016/j.toxicon.2010.07.001 · DOI
- Segura, 2009, Stability of equine IgG antivenoms obtained by caprylic acid precipitation: towards a liquid formulation stable at tropical room temperature, Toxicon, 53, 609, 10.1016/j.toxicon.2009.01.012 · doi:10.1016/j.toxicon.2009.01.012
- Segura, 2010, Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa, Toxicon, 55, 369, 10.1016/j.toxicon.2009.08.010 · DOI
- Sharma, 2004, Impact of snake bites and determinants of fatal outcomes in southeastern Nepal, Am. J. Trop. Med. Hyg., 21, 234, 10.4269/ajtmh.2004.71.234 · doi:10.4269/ajtmh.2004.71.234
- Simpson, 2008, A study of the current knowledge base in treating snake bite amongst doctors in the high-risk countries of India and Pakistan: does snake bite treatment training reflect local requirements?, Trans. R. Soc. Trop. Med. Hyg., 102, 1108, 10.1016/j.trstmh.2008.04.013 · DOI
- Snow, 1994, The prevalence and morbidity of snake bite and treatment-seeking behaviour among a rural Kenyan population, Ann. Trop. Med. Parasitol., 88, 665, 10.1080/00034983.1994.11812919 · doi:10.1080/00034983.1994.11812919
- Stock, 2007, Bringing antivenoms to sub-Saharan Africa, Nat. Biotechnol., 25, 173, 10.1038/nbt0207-173 · doi:10.1038/nbt0207-173
- Swaroop, 1954, Snakebite mortality in the world, Bull. World Health Organ., 10, 35
- Theakston, 1983, Development of simple standard assay procedures for the characterization of snake venom, Bull. World Health Organ., 61, 949
- Theakston, 2000, Crisis in snake antivenom supply for Africa, Lancet, 356, 2104, 10.1016/S0140-6736(05)74319-1 · DOI · Paper page
- Theakston, 2003, Report of a WHO workshop on the standardization and control of antivenoms, Toxicon, 41, 541, 10.1016/S0041-0101(02)00393-8 · DOI · Paper page
- Trape, 2001, High mortality from snakebite in south-eastern Senegal, Trans. R. Soc. Trop. Med. Hyg., 95, 420, 10.1016/S0035-9203(01)90202-0 · doi:10.1016/s0035-9203(01)90202-0
- Vargas, 2011, Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea, PLoS Negl. Trop. Dis., 5, e1144, 10.1371/journal.pntd.0001144 · doi:10.1371/journal.pntd.0001144
- Visser, 2008, Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance, Trans. R. Soc. Trop. Med. Hyg., 102, 445, 10.1016/j.trstmh.2007.11.006 · DOI
- Warrell, 2008, Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product-‘what’s in a name?’, Trans. R. Soc. Trop. Med. Hyg., 102, 397, 10.1016/j.trstmh.2007.12.005 · doi:10.1016/j.trstmh.2007.12.005
- Warrell, 2010, Snake bite, Lancet, 375, 77, 10.1016/S0140-6736(09)61754-2 · DOI · Paper page
- Williams, 2010, The Global Snake Bite Initiative: an antidote for snake bite, Lancet, 375, 89, 10.1016/S0140-6736(09)61159-4 · DOI · Paper page
- Williams, 2011, Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa, J. Proteomics, 74, 1735, 10.1016/j.jprot.2011.05.027 · DOI · Paper page
- Williams, 2011, Delayed psychological morbidity associated with snakebite envenoming, PLoS Negl. Trop. Dis., 5, e1255, 10.1371/journal.pntd.0001255 · DOI
Cited by
Gutiérrez, J. M., Calvete, J. J., Habib, A. G., Harrison, R. A., Williams, D. J., & Warrell, D. A. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.63 · Cited by 955
Self-citationSnake Antivenoms—Toward Better Understanding of the Administration Route
Gamulin, E., Mateljak Lukačević, S., Halassy, B., & Kurtović, T. (2023) · Toxins · doi:10.3390/toxins15060398 · Cited by 30
Ranéia e Silva, P. A., de Lima, D. S., Mesquita Luiz, J. P., Câmara, N. O. S., Alves-Filho, J. C. F., Pontillo, A., Bortoluci, K. R., & Faquim-Mauro, E. L. (2021) · Clinical Science · doi:10.1042/cs20201419 · Cited by 30
Smith, C. F., Modahl, C. M., Ceja Galindo, D., Larson, K. Y., Maroney, S. P., Bahrabadi, L., Brandehoff, N. P., Perry, B. W., McCabe, M. C., Petras, D., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100779 · Cited by 11
Metadata
- Authors
- Gutiérrez, J. M.
- Venue
- Toxicon
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 60
- Issue
- 4
- Pages
- 676-687
- ISSN
- 0041-0101
- Cited by
- 104
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Vicerrectoría de Investigación (Universidad de Costa Rica)
- CONARE
- Fundación CRUSA
- NeTropica
- CYTED
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improving antivenom availability and accessibility: Science, technology, and beyond. https://app.cochat.ai/papers/10.1016/j.toxicon.2012.02.008
- The paper
- Gutiérrez, J. M. (2012). Improving antivenom availability and accessibility: Science, technology, and beyond. Toxicon. https://doi.org/10.1016/j.toxicon.2012.02.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.